OCTOPLUS Aktie

0,45 EUR 6,8396%

Zu Ihrem Onlinebroker

kaufen verkaufen

OCTOPLUS Aktienkurs : 25.05. ( 15 Min. verzögert)
0,453 € Letzter Kurs	6,84% Veränderung	0,424 € Vortag	0,453 € Eröffnungskurs

Realtime:

0,45

6,84%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,453 - 0,426 Tag	0,0000000 - 0,0000000 52 Wochen	0 Tag	6 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

OCTOPLUS Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Glaxo acquisitions hedge its bets

Among companies Glaxo has stakes in are Anacor Pharmaceuticals, with which it's developing an antibiotic for infections caused by Gram-negative bacteria, and Octoplus, which offers drug-delivery technologies for biological compounds.
16.05.

Global Human Vaccines Industry

... Develop RSV Vaccine II-144SciGen and OctoPlus Join Forces to Develop Hepatitis BVaccine Delivery II-144AlphaVax Receives Patent for Alphavaccines Manufacturing Process II-144IVI Receives Funds for Cholera Vaccine...

16.05.

Octoplus publishes first quarter business update

Leiden, the Netherlands, 16 May 2012 - OctoPlus NV ("OctoPlus" or the "Company") (Euronext: OCTO) today publishes its business update for the first quarter of 2012. Highlights In...
10.05.

SurModics Reports Second Quarter Fiscal Year 2012 Results

In addition, during the second quarter of 2012 the Company recorded an $0.8 million impairment loss on our OctoPlus equity investment. Excluding the impact of Cypher, revenue increased 4% from the year ago period. Adjusting for Cypher items and...
08.05.

SurModics Reports Second Quarter Fiscal Year 2012 Results

In addition, during the second quarter of 2012 the Company recorded an $0.8 million impairment loss on our OctoPlus equity investment. Excluding the impact of Cypher, revenue increased 4% from the year ago period. Adjusting for Cypher items and...